Innate and Adaptive Cell-Mediated Immune Responses to a COVID-19 mRNA Vaccine in Young Children.

Adriana WeinbergMichael J JohnsonKrystle GarthElena W Y HsiehRoss KedlDaniela WeiskopfMattie CassadayCody ResterBerenice Cabrera-MartinezRyan M BaxterMyron J Levin

Published in: Open forum infectious diseases (2023)

Children aged 6 to 60 months who were vaccinated with a COVID-19 mRNA vaccine developed robust CMI responses, including adaptive and innate immunity.

Keyphrases

immune response
coronavirus disease
sars cov
single cell
binding protein
dendritic cells
cell therapy
respiratory syndrome coronavirus
toll like receptor
mesenchymal stem cells